DOCSLIB.ORG

Medical JOUR

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medical JOUR RHODE ISLAND M EDiCAL J ournal ZOOM – It’s a Match! Virtual National Match Day is largest on record See page 75 R SPECIAL SECTION, PART II BIOMEDICAL/TRANSLATIONAL RESEARCH in RI GUEST EDITORS: JAMES PADBURY, MD; BONGSUP CHO, PhD ApRiL 2021 VOLUME 104 • NUMBER 3 iSSN 2327-2228 REINVENTING WHAT YOU EXPECT FROM A MEDICAL PROFESSIONAL LIABILITY PROVIDER. With Coverys, you can reduce the distractions that come between diagnosis and outcomes. By leveraging claims data and analytics plus innovative educational resources, we’re helping doctors and administrators reduce distractions and focus on improving clinical, operational, and financial outcomes.Visit coverys.com Insurance products issued by ProSelect® Insurance Company (NE, NAIC 10638) and Preferred Professional Insurance Company® (NE, NAIC 36234). RHODE ISLAND M EDICAL J OURNAL 15 Translational Research: The Time is Now JAMES F. PADBURY, MD BONGSUP P. CHO, PhD GUEST EDITORS James F. Padbury, MD Bongsup Cho, PhD 17 The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial ADAM J. CZYNSKI, DO; ABBOT R. LAPTOOK, MD 22 COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond TRACI C. GREEN, PhD, MSc; ELIANA KAPLOWITZ, BA; KIRSTEN LANGDON, PhD; JACLYN M.W. HUGHTO, PhD, MPH; WILLIAM C. GOEDEL, PhD; ADAM J. CZYNSKI, DO; GAYLE FRASER, BS; JOSIAH RICH, MD, MPH 27 Brown University COBRE Center for Addiction and Disease Risk Exacerbation PETER M. MONTI, PhD; JENNIFER W. TIDEY, PhD; JASJIT S. AHLUWALIA, MD 32 The Center of Biomedical Research Excellence (COBRE) for Perinatal Biology – Accomplishments, Impact, and Long-term Results SUNIL K. SHAW, PhD 36 Rhode Island COBRE Center for Central Nervous System Function: Progress and Perspectives JEROME N. SANES, PhD 41 Advance-CTR: Statewide Infrastructure to Improve Health in Rhode Island through Clinical and Translational Research VALERIE ZABALA, PhD; GABRIELLE STRANIERI, BA; HEATHER FOURNIER, MA; EDWARD HAWROT, PhD; JAMES F. PADBURY, MD 3 RHODE ISLAND M EDICAL J OURNAL 8 VINTAGE COMMENTARY Searching for a Lost Cousin during the Depression and War Years Tribute to an Israeli physician STANLEY M. ARONSON, MD 10 COMMENTARY New Rules for Patient Data Sharing Risk Harm to our Most Vulnerable JESSICA J. POURIAN, MD; DANIEL COGHLIN, MD Cognitive Sinks & the Bermuda Triangle of fMRI Cognitive Studies JOSEPH H. FRIEDMAN, MD 14 LETTER TO THE EDITORS ‘Man Therapy’ website addresses suicide risk in men Program introduced in Washington County ROBERT HARRISON, Jr., MD AMA statement on CMS decision to update Medicare payments for administrating COVID-19 vaccine SUSAN R. BAILEY, MD 66 RIMS NEWS Working for You 70 RIMJ OUT OF THIS WORLD Jezero Crater, Mars 71 SPOTLIGHT ‘Smart Bandage’ detects, could prevent infections URI chemical engineering professor embeds nanosensors in microfibers to create ‘smart bandage’ 4 RHODE ISLAND M EDICAL J OURNAL IN THE NEWS VACCINATION IN RI 72 77 BUTLER HOSPITAL new State-run sites open investigational drug for AD treatment shows significant results in slowing symptoms VACCINE ELIGIBILITY 72 expands for Veterans, spouse, caregivers 77 PROVIDENCE VA heart failure with reduced ejection fraction CDC REAL-WORLD STUDY 73 treatment study funded confirms protective benefits of mRNA COVID-19 vaccines 78 RHODE ISLAND HOSPITAL memory disorders researcher launches landmark RI DEPArtmENT OF HEALTH 73 study of brain health following major surgeries updates monoclonal antibody treatment regimens 78 HASBRO HOSPITAL WORLD HEALTH ORGANIZATION (WHO) 74 PRoMPT BOLUS study measures potential calls for further studies, data on origin of SARS-CoV-2 improvement in children with sepsis virus, reiterates that all hypotheses remain open 79 URI COLLEGE OF PHARMACY VirtUAL MATCH DAY 75 among best in nation in postdoctoral at Brown residency placement rate 2021 RESIDENCY MATCH 76 79 RHODE ISLAND HEALTH CARE PROVIDERS largest on record join nationwide movement to improve older adults’ care PEOPLE/PLACES MArthA L. WOFFORD 80 81 JAMES K. SULLIVAN, MD, PhD named BCBSRI president named CMO at and CEO CNE Medical Group TRACEY M. GUTHRIE, MD 80 82 NIKOS TAPINOS, MD, PhD named Chair-Elect, American Association of earns Bruce M. Selya Award Directors of Psychiatric for Excellence in Research Residency Training 83 Ortho RHODE ISLAND celebrates opening of flagship LINDA L. CARPENTER, MD 81 campus in Warwick named President-Elect of the Society of 83 ROGER WILLIAMS MEDICAL CENTER Biological Psychiatry opens Behavioral Health and Substance Use Emergency Treatment Unit STAR HAMPTON, MD 81 named Chief Education 84 OBITUARIES Officer at CNE William D. Graham, MD Howard Sturim, MD Leonard Jason Triedman, MD Robin Wallace, MD 5 ApRiL 2021 VOLUME 104 • NUMBER 3 RHODE ISLAND Rhode Island Medical Society R I Med J (2013) M EDiCAL J ournal PUBLISHER 2327-2228 RHODE ISLAND MEDICAL SOCIETY 104 PRESIDENT CATHERINE A. CUMMINGS, MD 3 PRESIDENT-ELECT 2021 ELIZABETH B. LANGE, MD VICE PRESIDENT THOMAS A. BLEDSOE, MD April IMAGES IN MEDICINE Secretary 46 Spontaneous Pneumomediastinum in a Healthy 25-Year-Old Male KARA STAVROS, MD 1 JULIE WOODSIDE, PA-C; RICHARD V. MORGERA, MD TREASURER KWAME DAPAAH-AFRIYIE, MD, MBA 49 Pneumomediastinum in a Patient with EXECUTIVE DIRECTOR Cannabinoid Hyperemesis Syndrome NEWELL E. WARDE, PhD MARC J. VECCHIO, MD; WILLIAM D. BINDER, MD, FACEP EDITORS-IN-CHIEF WILLIAM BINDER, MD EDWARD FELLER, MD CASE Report ASSociate EDITOR 51 Chin Numbness as a Presenting Symptom of Malignancy KENNETH S. KORR, MD CHRISTIAN E. BUSTAMANTE, MD; KYLE DENISON MARTIN, DO, MPH, DTM&H; EDITOR-IN-CHIEF EMERITUS JOSEPH H. FRIEDMAN, MD EMILY COLYER, DO PUBlication Staff MANAGING EDITOR CONTRIBUTIONS MARY KORR 53 Characterizing the Symptoms of Patients with Persistent [email protected] Post-Treatment Lyme Symptoms: A Survey of Patients GRAPHIC DESIGNER at a Lyme Disease Clinic in Rhode Island MARIANNE MIGLIORI SARA E. VARGAS, PhD; MEGHAN MCCARTHY, ScB; MATTHEW BOUDREAU, BA; ADvertiSING ADMINIStrator DYLAN CANFIELD, BA; REBECCA REECE, MD; TIMOTHY FLANIGAN, MD DULCINEIA COSME [email protected] 58 How to Build It So They’ll Come: Faculty Opinion on Faculty Development JENNIFER JEREMIAH, MD; KELLY MCGARRY, MD; JOAO FILIPE MONTEIRO, PhD; DOMINICK TAMMARO, MD PUBLIC HEALTH 62 HEALTH BY NUMBERS The Association between Exercise in the Last Trimester of Pregnancy and Low Infant Birthweight among Rhode Island Mothers, 2016–2018 SCARLETT BERGAM, BA; KARINE MONTEIRO, MPH; MORGAN ORR, MPH; ANNIE GJELSVIK, PhD RHODE ISLAND MEDICAL JOURNAL (USPS 464-820), a monthly publication, is owned and published by the Rhode Island Medical Society, 405 Promenade Street, Suite 65 Vital Statistics A, Providence RI 02908, 401-331-3207. All ROSEANN GIORGIANNI, DEPUTY STATE REGISTRAR rights reserved. ISSN 2327-2228. Published articles represent opinions of the authors and do not necessarily reflect the official policy of the Rhode Island Medical Society, unless clearly specified. Advertisements do not im- ply sponsorship or endorsement by the Rhode Island Medical Society. © COPyright 2013–2021, RHODE ISLAND MEDICAL SOCIETY, ALL RIGHTS RESERVED. 6 Your patient care model has evolved. Has your risk management kept pace? Telemedicine creates new opportunities for healthcare organization, but it also comes with a whole new set of hidden risks, including increased cybersecurity, liability claims, and compliance gaps. You need a partner who can help you keep up with emerging risks. HUB can help. Our insurance and risk management specialists can keep you protected — so you can continue to focus on patient care. hubinternational.com/rimed Put our resources to work for you. Daniel Nissi, LIA 508-259-9480 [email protected] Risk & Insurance | Employee Benefits | Retirement & Private Wealth VINTAGE Commentary [Editor’s Note: The following commentary was written by the late Stanley M. Aronson, MD, founding dean of the Alpert Med- ical School of Brown University, who served as Editor-in-Chief of the Rhode Island Medical Journal for more than a decade.] Searching for a Lost Cousin during the Depression and War Years Tribute to an Israeli physician STANLEY M. ARONSON, MD 8 9 EN IF THEY ACHIEVED LITTLE to purchase postal money get to Turkey, where he was currently else, the Depression years orders, which were then living or whether his parents were yet of the 20th Century left us faithfully mailed to the alive. The family had no way of commu- with enduring memories. old country. And each nicating with him and the weeks that hor Stanley M. Aronson, MD, Found- Those early Depression month we received word followed were weeks of anguish. ing dean of the Alpert Medical years witnessed bank fail- from Europe of Cousin Months passed with no further word School of Brown University; for- mer Editor-in-Chief of the Rhode ures, families evicted from Hugo’s educational prog- from Hugo and during that interval we Island Medical Journal for more their homes for failure to ress, how well he did and learned from other sources that Hugo’s than a decade.] pay rent, soup kitchens on finally, in 1936, when he family back in Czernowitz were all major street corners and was admitted to medical victims of the Holo- In the early spring ill-clad men wandering school in the city of Cluj, caust. Hugo’s letter, the streets at midday seek- in northern Romania. by then a precious of 1946, when I was ing itinerant employment. But there family document, returning from the was also a fragile sense of hope that the September 1939: was read and reread Army, I received a recent election of President Franklin War breaks out in Europe during the months D. Roosevelt might counteract the When war arrived in Europe on the first of silence. Early call from my mother economic and emotional despondency day of September 1939, my family lost in 1947 we finally excitedly exclaiming, which gripped the nation in 1932. contact with Hugo and his family.
Load more

Recommended publications
  • June 11, 2021 the Honorable Xavier Becerra Secretary Department of Health and Human Services 200 Independence Ave S.W. Washingto
    June 11, 2021 The Honorable Xavier Becerra Secretary Department of Health and Human Services 200 Independence Ave S.W. Washington, D.C. 20201 The Honorable Francis Collins, M.D., Ph.D. Director National Institutes of Health 9000 Rockville Pike Rockville, MD 20892 Dear Secretary Becerra and Director Collins, Pursuant to 5 U.S.C. § 2954 we, as members of the United States Senate Committee on Homeland Security and Governmental Affairs, write to request documents regarding the National Institutes of Health’s (NIH) handling of the COVID-19 pandemic. The recent release of approximately 4,000 pages of NIH email communications and other documents from early 2020 has raised serious questions about NIH’s handling of COVID-19. Between June 1and June 4, 2021, the news media and public interest groups released approximately 4,000 pages of NIH emails and other documents these organizations received pursuant to Freedom of Information Act requests.1 These documents, though heavily redacted, have shed new light on NIH’s awareness of the virus’ origins in the early stages of the COVID- 19 pandemic. In a January 9, 2020 email, Dr. David Morens, Senior Scientific Advisor to Dr. Fauci, emailed Dr. Peter Daszak, President of EcoHealth Alliance, asking for “any inside info on this new coronavirus that isn’t yet in the public domain[.]”2 In a January 27, 2020 reply, Dr. Daszak emailed Dr. Morens, with the subject line: “Wuhan novel coronavirus – NIAID’s role in bat-origin Covs” and stated: 1 See Damian Paletta and Yasmeen Abutaleb, Anthony Fauci’s pandemic emails:
    [Show full text]
  • Melissaossmanpro.Pdf
    August 19, 2021 Chairman Lipps, Vice Chair Holmes, Ranking Member Russo, and Members of the House Health Committee, thank you for the opportunity to provide proponent testimony on House Bill 248. My family and I are asking that Ohio HB248 be passed in order to protect the individual freedoms we currently have as American citizens. I work in a corporate setting and my husband owns a small business. We have two young daughters who are relying on us to provide for them and protect their rights. I support this bill in hopes that they can grow up with the same liberties we have had. Segregation and discrimination over individual health choices should be taken seriously and passing this bill is key to avoiding those types of issues in the future. I am not a scientist, but I am a mom, a wife, and a daughter who takes the health of my family very seriously. I have done extensive amounts of research on the SARS-COV2 virus and subsequent vaccines. There are also many health experts that provide me with helpful information. I am sure you are receiving many testimonies about the large numbers of vaccine injuries and even deaths that have occurred during this vaccine campaign. Personally, I know two women who have had severe menstrual issues (requiring surgery) that they can connect back to occurring right after the vaccine. My friends’ cousin passed away at only 23 years old from an enlarged heart after receiving the vaccine. The stories go on and on. The point is that no legislation should force my family and I to inject ourselves with substances that have side effects such as this.
    [Show full text]
  • The Highly Pathogenic Avian Influenza A(H5N1) Virus: a Twenty-Year Journey of Narratives and (In)Secure Landscapes
    The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert Dissertation submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Science, Technology, and Society Barbara L. Allen (Chair) Daniel Breslau Bernice L. Hausman David C. Tomblin March 18, 2016 Falls Church, Virginia Keywords: H5N1, HPAI, highly pathogenic avian influenza virus, pandemic, social justice, bioterrorism, bioethics, biopower, tacit knowledge, dual-use dilemma, dual-use research of concern, emerging infectious disease Copyright Philip R. Egert The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert ABSTRACT This dissertation is comprised of two manuscripts that explore various contestations and representations of knowledge about the highly pathogenic avian influenza H5N1virus. In the first manuscript, I explore three narratives that have been produced to describe the 20-year journey of the virus. The journey begins in 1996 when the virus was a singular localized animal virus but then over the next 20 years multiplied its ontological status through a (de)stabilized global network of science and politics that promoted both fears of contagion and politics of otherness. Written by and for powerful actors and institutions in the global North, the narratives focused on technical solutions and outbreak fears. In doing so, the narratives produced policies and practices of biopower that obscured alternative considerations for equity, social justice, and wellbeing for the marginalized groups most directly affected by the H5N1 virus.
    [Show full text]
  • Emergence of Highly Infectious SARS-Cov-2 Variants in Bangladesh
    Hasan et al. Trop Med Health (2021) 49:69 https://doi.org/10.1186/s41182-021-00360-w Tropical Medicine and Health LETTER TO THE EDITOR Open Access Emergence of highly infectious SARS-CoV-2 variants in Bangladesh: the need for systematic genetic surveillance as a public health strategy Mohammad Mehedi Hasan1,2, Ian Christopher N. Rocha3, Kimberly G. Ramos3, Trisha Denise D. Cedeño3, Ana Carla dos Santos Costa4, Christos Tsagkaris5, Md. Masum Billah6, Shoaib Ahmad7 and Mohammad Yasir Essar8* Abstract Bangladesh, a low-middle-income country in South Asia is facing one of its worst public health emergencies due to the COVID-19 pandemic. The increase in the number of cases from the disease, since the second half of March 2021, can potentially cause the health system overload, and has, as one of the main reasons, the non-compliance with measures of social distance and the emergence of the variants of concern in the country. This increase in the contagion curve can also provide a favorable environment for the occurrence of more mutations in the structure and genome of the virus. Therefore, there is an urge to carry out genomic surveillance programs in order to identify, moni- tor and characterize these variants, and understand whether the vaccines currently used are efective against them. Keywords: Bangladesh, SARS-CoV-2 variants, Public health, Genetic surveillance Dear editor, in the country began to increase during the middle of Te ongoing Coronavirus Disease 2019 (COVID-19) March 2021. Initially, there was a drop in the number of pandemic is a major burden to health systems world- cases during February 2021, in which the lowest monthly wide, constituting the worst health crisis in history.
    [Show full text]
  • Peter Daszak IPBES Scoping for the Nexus Assessment: Health
    IPBES Scoping for the Nexus Assessment: Health & Linkages Peter Daszak [email protected] The focus for this session Three thematic areas: 1. Biodiversity & health 2. Global environmental change & health 3. Food, water & health Your suggestions on: • Scope of the assessment • Questions to address Post-2020 Biodiversity Framework and Global Goals . Aichi Biodiversity Targets, particularly: • Target 14. Biodiversity and Ecosystem Services . Sustainable Development Goals, e.g.: • 3. Health; • 6. Clean Water and Sanitation; • 13. Climate Action; • 14. Aquatic Ecosystems; • 15. Terrestrial Ecosystems; • 17. Partnerships . Global Health Security Agenda (Prevent, Detect, Respond) . Sendai Framework for Disaster Risk Reduction 2015-2030 • Bangkok Principles for implementation of health aspects One Health approach • Health of people, wildlife, livestock, environment • Impact of human-mediated global environmental change on health across all sectors Biodiversity’s Health Services Pharmaceuticals • Penicillin (fungus); Digitalis (foxglove plant); Quinine and quinidine (Peruvian Cinchona tree); Morphine and codeine (poppies); Taxol (Pacific Yew tree) Welfare • Link between good mental health and open spaces, biodiversity, forests/parks • Outdoor activity linked to overall fitness and lack of disease • Dietary diversity and nutritional health Protection against disease • Lower risk emerging diseases from undisturbed intact forest Honey Bee Declines in U.S.A. Biodiversity loss & health Intact Forest Residential Urban Culex mosquitoes prefer
    [Show full text]
  • ISSUE #9 from the Red Patriot Show Some Articles May Require Subscriptions
    J E u l y H 1 T 4 The News t Red R eport h The People • The Right Way , ' 2 1 ISSUE #9 from The Red Patriot Show Some articles may require subscriptions CHINESE-MADE COVID-19 VACCINE RECIPIENTS WON’T COUNT AS VACCINATED: SINGAPORE The Epoch Times Singapore’s health agency said that individuals who have received the Chinese-made COVID-19 vaccine won’t count as being vaccinated. BIDEN ADMIN TO GO “The national vaccination numbers reflect only those vaccinated under the national vaccination program,” the country’s Ministry of ‘DOOR-TO-DOOR’ TO Health said on Tuesday. “Currently, this only includes those vaccinated VACCINATE PEOPLE with the Moderna COVID-19 and Pfizer-BioNTech/Comirnaty vaccines.” America's C itizen Press COVID-19 is the disease caused by the CCP (Chinese Communist Party) virus, otherwise known as the coronavirus. President Joe Biden’s administration plans to go door-to-door to vaccinate people against COVID-19. The city-state’s health officials said there is inadequate efficacy data for “Now we need to go to community-by-community, neighborhood- the Sinovac COVID-19 vaccine, namely against the Delta strain. The by-neighborhood, and oft-times door-to-door, literally knocking variant has become the most prevalent COVID-19 strain in the country. on doors,” said Biden. Watch Biden threaten to send government officials to your door to make you take an OPTIONAL vaccine. WATCH BIDEN While answering a question, Biden appeared to lose his train STRUGGLE TO of thought and completely SPEAK YET forget the name Osama Bin Laden for about five to six AGAIN seconds.
    [Show full text]
  • Assessing SARS-Cov-2 Circulation, Variants of Concern, Non-Pharmaceutical Interventions and Vaccine Rollout in the EU/EEA, 15Th Update 10 June 2021
    RISK ASSESSMENT Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update 10 June 2021 Summary Although SARS-CoV-2 transmission remains widespread in large parts of the EU/EEA, most countries report declining trends in 14-day COVID-19 notification rates, hospital and intensive care unit (ICU) occupancy, and mortality. Many countries have initiated partial lifting of different non-pharmaceutical interventions (NPIs) that aim to reduce the degree of citizens physical contact and mobility. Since January 2021, EU/EEA countries have reported an increase in the number and proportion of SARS-CoV-2 cases of variants of concern (VOC) associated with increasing transmissibility and/or severity, with Alpha (B.1.1.7) the current dominant variant across the EU/EEA. Estimates across the region show that a large proportion of the population across Europe still remains susceptible to SARS-CoV-2 and that population immunity is far from being reached. As of 3 June, the median cumulative vaccine uptake in the EU/EEA adult population (aged 18 years and older) had reached 46.2% for at least one vaccine dose and 22.3% for the full vaccination course. The highest level of vaccine uptake was observed among the elderly aged over 80, in which the uptake reached 80.5% for at least one dose and 66.3% for full vaccination coverage. For healthcare workers, the median level of at least one dose uptake was 87% and the median uptake for the full vaccination course was 65.2%. Increased vaccine supply has allowed countries to expand eligibility for vaccination to younger age groups.
    [Show full text]
  • Doctors' Mental Health in the Midst of COVID-19 Pandemic
    International Journal of Environmental Research and Public Health Article Doctors’ Mental Health in the Midst of COVID-19 Pandemic: The Roles of Work Demands and Recovery Experiences 1,2, 1, , 3 Mohd Fadhli Mohd Fauzi y , Hanizah Mohd Yusoff * y, Rosnawati Muhamad Robat , Nur Adibah Mat Saruan 1,2 , Khairil Idham Ismail 1,2 and Ahmad Firdaus Mohd Haris 4 1 Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, Kuala Lumpur 56000, Malaysia; [email protected] (M.F.M.F.); [email protected] (N.A.M.S.); [email protected] (K.I.I.) 2 Ministry of Health Malaysia, Federal Government Administrative Centre, Putrajaya 62590, Malaysia 3 Occupational and Environmental Health Unit, Selangor State Health Department, No 1, Wisma Sunway, Jalan Tengku Ampuan Zabedah C 9/C, Seksyen 9, Shah Alam, Selangor 40100, Malaysia; [email protected] 4 Non-Communicable Diseases Unit, Perak State Health Department, Jalan Koo Chong Kong, Ipoh 30000, Perak, Malaysia; ahmad.fi[email protected] * Correspondence: [email protected]; Tel.: +60-3-9145-5904 These authors contributed equally to this work. y Received: 18 September 2020; Accepted: 5 October 2020; Published: 8 October 2020 Abstract: The COVID-19 pandemic potentially increases doctors’ work demands and limits their recovery opportunity; this consequently puts them at a high risk of adverse mental health impacts. This study aims to estimate the level of doctors’ fatigue, recovery, depression, anxiety, and stress, and exploring their association with work demands and recovery experiences. This was a cross-sectional study among all medical doctors working at all government health facilities in Selangor, Malaysia.
    [Show full text]
  • Social Distancing and Supply Disruptions in a Pandemic∗
    Social Distancing and Supply Disruptions in a Pandemic∗ Martin Bodenstein Giancarlo Corsetti Luca Guerrieri Federal Reserve Board University of Cambridge Federal Reserve Board June 18, 2020 Abstract Drastic public health measures such as social distancing or lockdowns can reduce the loss of human life by keeping the number of infected individuals from exceeding the capacity of the health care system but are often criticized because of the social and economic costs they entail. We question this view by combining an epidemiological model, calibrated to capture the spread of the COVID-19 virus, with a multisector model, designed to capture key characteristics of the U.S. Input Output Tables. Our two-sector model features a core sector that produces intermediate inputs not easily replaced by inputs from the other sector, subject to minimum-scale requirements. We show that, by affecting workers in this core sector, the high peak of an infection not mitigated by social distancing may cause very large upfront economic costs in terms of output, consumption and investment. Social distancing measures can reduce these costs, especially if skewed towards non-core industries and occupations with tasks that can be performed from home, helping to smooth the surge in infections among workers in the core sector. JEL classifications: E1, E3, I1. Keywords: infectious disease, epidemic, recession, COVID-19. ∗ The views expressed in this paper are solely the responsibility of the authors and should not be interpreted as reflecting the views of the Board of Governors of the Federal Reserve System or of any other person associated with the Federal Reserve System.
    [Show full text]
  • Lessons from COVID-19 to Help Prevent Future Pandemics
    China CDC Weekly Commentary Lessons from COVID-19 to Help Prevent Future Pandemics Peter Daszak# In just over 12 months since it was first discovered, that allow diseases like COVID-19 to spread globally coronavirus disease 2019 (COVID-19) has caused over within days or weeks (4). Understanding these 100 million confirmed cases and more than 2.2 million patterns, provides the elements of a prevention deaths. Its impact on our global economy has been strategy. staggering and likely to be in the tens of trillions of The first step in any battle is to know your enemy, dollars by the time vaccines are fully deployed (1). and in this case identify the size of the threat and COVID-19 has caused significant hardship, mortality, where it’s coming from. Given that viruses are the and morbidity across the world, from the lockdowns predominant group of pathogens and that most viral experienced by the citizens of Wuhan in early 2020, zoonoses are acquired from mammalian hosts, we through to the waves of case spikes in European, North repeatedly sampled two species of mammals (a fruit bat American, and other countries. Pandemics of this scale and primate) and conducted the same viral discovery are rare, and many have called COVID-19 a once-in-a- protocol on each sample. Using data on the rate of century pandemic, but our research suggests that they discovery of new strains compared to repeat findings, are increasing in frequency, driven by a rise in the we were able to estimate the unknown diversity of animal-to-human pathogen spillover events that viruses in all mammal species — around 1.6 million usually cause them (2).
    [Show full text]
  • Lesson Learned from Emerging Infectious Diseases: Are We Ready for the Next Pandemic?
    Lesson Learned from Emerging Infectious Diseases: Are We Ready for the Next Pandemic? Ching Man Chan, Jenny (2nd year Mphil) Supervisor: Dr. Martin Chan Joint Graduate Seminar Department of Microbiology, Faculty of Medicine, CUHK 13th December, 2018 1 What are Emerging Infectious Diseases? Why does it matters? Emerging Infectious Diseases (EIDs) Definition Increasing frequency to describe the appearance of 1. An unrecognised infection 2. A previously recognised infection → to a new ecological niche/geographical zone → significant change in pathogenicity Facts o Infectious diseases are continuously emerging o Majority of human emerging infectious diseases are zoonoses o Those that are not zoonoses have zoonotic origins o Globalisation and human invasiveness → emergence opportunities (Howard and Fletcher, Emeging Microbes and Infections, 2012; van Doorn, Medicine (Abingdon), 2014) Severity of Emerging Infectious Diseases (Bean et al. Nature Reviews Immunology, 2013) List of Blueprint Priority Diseases 2018 o Crimean-Congo haemorrhagic fever (CCHF) o Ebola virus disease and Marburg virus disease o Lassa fever o Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS) o Nipah and henipaviral diseases o Rift Valley fever (RVF) o Zika o Disease X Why most of them are viral diseases? Where do they come from and how they evolve to infect human? Mutation Rate V.S. Genome Size (Gago et al. Science, 2009) Many of the viruses are UNKNOWN (Dr Peter Daszak’s talk on “The beginning of an end to the Pandemic Era”, Uppsala Health Summit, 2017) Emergence of Zoonoses (Wolfe, Dunavan and Diamond. Nature, 2007) Multiple Species Barrier to become Zoonotic (Bean et al.
    [Show full text]
  • The Hunt for Coronavirus Carriers
    Feature ILLUSTRATION BY DAVID PARKINS DAVID BY ILLUSTRATION t was the news Sophie Gryseels had been dreading for months. Almost a year into the pandemic, a seemingly healthy wild mink tested positive for SARS-CoV-2 in Utah. No free-roaming animal was known to have caught the virus before, although research- ers had been watching for this closely. “It’s THE HUNT FOR happened,” wrote Gryseels, an evolution- Iary biologist at the University of Antwerp, Belgium, in an e-mail to her colleagues. Ever since the coronavirus started spreading around the world, scientists have worried that it could leap from people into wild animals. If CORONAVIRUS so, it might lurk in various species, possibly mutate and then resurge in humans even after the pandemic has subsided. That would bring the tale of SARS-CoV-2 full circle, because wild animals probably brought it to humans in the first place. Strong evidence suggests that the virus originated in horseshoe CARRIERS bats (Rhinolophus spp.), possibly hitching a ride on other animals before infecting people1. In the To prevent future outbreaks, scientists current stage of the pandemic, with hundreds of thousands of confirmed COVID-19 infections are studying how the coronavirus leaps every day, people are still driving transmission from humans to animals — and back again. of SARS-CoV-2. But years from now, when com- munity spread has been suppressed, a reservoir By Smriti Mallapaty of SARS-CoV-2 in free-roaming animals could become a recalcitrant source of new flare-ups. Wild animals are not the only ones to have drawn scrutiny.
    [Show full text]